20 likes | 32 Views
The global cardiovascular devices market size was USD 49.90 billion in 2018 and is projected to reach USD 82.20 billion by 2026, exhibiting a CAGR of 6.4% during the forecast period.
E N D
Title: Cardiovascular Devices Market to Rise at 6.4%CAGR Cardiovascular Devices Market: Rising Awareness and Increasing Demand for Cardiovascular Surgical Devices will Promote MarketGrowth Description: Medtronic, Abbott, and Boston Scientific Corporation to Hold Majority Share in Cardiovascular Devices Market: Key Players to Primarily Focus on Production of Advanced CardiovascularDevices Cardiovascular Devices Market is Gaining Popularity from Advent of Technological Therapeutics in Medical Sector, says Fortune BusinessInsights™ Content: The global cardiovascular devices market sizeis prognosticated to reachUSD 82.20 billion by 2026 on account of the increasing cases of cardiovascular diseases such as coronary artery disease, heart failure, congenital heart disease, heart attack, cardiomyopathy, and others. The increasing geriatric population and their vulnerability towards various chronic diseases, especially heart diseases is a major factor propelling the cardiovascular devices market growth. This information is published in a recent report by Fortune Business insights™ titled,“Cardiovascular Devices Market Size, Share and Global Trend By Device Type (Diagnostic and Monitoring Devices, and Therapeutic and Surgical Devices), By Application (Coronary Artery Disease (CAD), Cardiac Arrhythmia, Heart Failure, and Others), By End User (Hospitals, Specialty Clinics, and Others), and Geography Forecast till 2026.”According to the report, the market size was USD 49.90 billion in 2018 and is projected to rise at a CAGR of 6.4% between 2019 and2026. An Overview of the Impact of COVID-19 on thisMarket: The emergence of COVID-19 has brought the world to a standstill. We understand that this health crisis has brought an unprecedented impact on businesses acrossindustries. However, this too shall pass. Rising support from governments and several companies can help in the fight against this highly contagious disease. There are some industries that are struggling and some are thriving. Overall, almost every sector is anticipated to be impacted by thepandemic. We are taking continuous efforts to help your business sustain and grow during COVID-19 pandemics. Based on our experience and expertise, we will offer you an impact analysis of corona virus outbreak across industries to help you prepare for thefuture. Click here to get the short-term and long-term impact of COVID-19 on this[Market]. Please visit: https://www.fortunebusinessinsights.com/cardiovascular-devices-market- 102418 Major GrowthDrivers: Rising Prevalence of Cardiovascular Diseases to BoostMarket
The most important factor driving the market is the increasing prevalence of cardiovascular diseases. This, coupled with the advent of advanced technological diagnostics for the diagnosis of heart diseases, is creating lucrative growth opportunities. Besides this, the increasing awareness and initiatives taken by regional governments are expected to propel the cardiovascular devices market growth. Additionally, major investments are made to cater to the rising demand for cardiovascular surgical devices, and this will help the market gain momentum in the forecastperiod. However, the market may be negatively impacted by the inability of vendors to invest in research and development of cardiovascular systems following its inefficiency with reimbursement models. Nevertheless, the advent of advanced safety and remote monitoring in the latest devices is likely to create lucrative growth opportunities for the market in the longrun. RegionalAnalysis Presence of Major Vendors Strengthening North America MarketShare Geographically, the global cardiovascular devices market is widespread into the regions of North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. Among these, North America is holding the major cardiovascular devices market share, followed by Europe. This is on account of the presence of major manufacturers in Canada and the U.S. On the other side, the market in Asia Pacific is likely to earn significant cardiovascular device market revenue on account of the rise in prevalence of cardiovascular diseases and the regulatory scenario of the market. To cite an example, the government of India confirmed a reduction in stent prices as compared to the international market such as the U.S. Such steps taken by the regional governments will help Asia Pacific market witness steady growth in the forthcoming years. More Trending Topics from Fortune BusinessInsights: Vitiligo Treatment Market Size, Share, Growth, Sales and Drivers Analysis ResearchReport 2026Vitiligo Treatment Market to Reach US$ 1,944.5 Mn by 2026; Ever Rising Demand for Advanced Treatment Options to Propel Market, says Fortune BusinessInsights